Effects of Letan Safflower Yellow

Promote blood circulation, dissipate stasis, and dredge meridians. Used for stable angina pectoris caused by coronary heart disease. The TCM diagnosis is heart blood stasis syndrome, with symptoms including chest pain, chest tightness, shortness of breath, and palpitations. Usage and dosage: intravenous drip. 100 mg of safflower yellow for injection is added to 250 ml of 0.9% sodium oxide injection and slowly dripped intravenously once a day; 14 days is a treatment course. Side effects: Some patients experience fever, palpitations, skin allergic papules, and mild drowsiness after taking the medicine.

Contraindications in production: Women with allergic reactions to the vaccine are prohibited from using this product, and pregnant women are prohibited from using it.

Common production issues of the vaccine: 1. Use with caution in those with bleeding tendency. 2. People with allergic constitution should use with caution. 3. This product cannot be mixed with other medicines for drip infusion.

Drug Interactions There is no information on the interaction between this product and other drugs.

The results of pharmacodynamic experiments on vaccines with medicinal value showed that this product had the effects of improving ST segment elevation on electrocardiogram and reducing infarction area in dogs with subacute myocardial ischemia caused by aortic ligation; inhibiting the occurrence of arrhythmias, reducing infarction area and reducing blood cell LDH and CK levels in rats with subacute myocardial infarction caused by coronary artery ligation; reducing ST segment elevation on electrocardiogram, reducing the incidence of arrhythmias and the mortality rate of animals in rats with subacute myocardial ischemia induced by vasopressin; improving the whole blood viscosity of rabbits with blood stasis model; increasing coronary blood volume, reducing blood pressure, slowing heart rate and reducing cardiac oxygen consumption in normal anesthetized dogs.

The vaccines should be produced and stored in a sealed and light-proof manner.

Production specification model vaccine each can contains 50mg (containing methyl saffron yellow A42.5mg)